top of page
AAO 2025: DELIVERY DEVICE SURGICAL SHOWCASE
Moderators: Robert Avery, MD, Program Co-Chair (Retina) and Rajesh Rajpal, MD, Program Co-Chair
Panel: Caroline R. Baumal, MD, Vitreoretinal Surgeon, Retina Specialists of Boston and Wellesley
and Mark Humayun, MD, PhD, Professor of Ophthalmology, University of Southern California
Room: W222
Start | Company | Presenter |
|---|---|---|
1:15 PM | Introduction | Robert Avery, MD |
1:16 PM | Neurotech Pharmaceuticals, Inc. | Beth Marsh, Chief Commerical Officer |
1:21 PM | Re-Vana Therapeutics | Michael J. O'Rourke, CEO |
1:26 PM | Valitor | Wesley M. Jackson, PhD, President & Chief Scientific Officer |
1:31 PM | Discussion | |
1:36 PM | EyeDura Therapeutics | Srini Venkatesh, PhD MBA, CEO |
1:41 PM | PolyActiva, Pty Ltd | Michael J. Brubaker, PhD, Chief Scientific Officer |
1:46 PM | Oculis | Riad Sherif, MD, CEO |
1:51 PM | Discussion | |
1:56 PM | Ashvattha Therapeutics, Inc. | Robert Dempsy |
2:01 PM | EyePoint | Jay S. Duker, MD, CEO & President |
2:06 PM | Ocular Therapeutix | Peter Kaiser, MD, Chief Development Officer |
2:11 PM | Discussion | |
2:16 PM | Long Bridge Medical | Ayman Naseri, MD, CEO |
2:21 PM | Dragonfleye Therapeutics Corp. | Rajeev H. Muni MD, MSc, FRCSC, CEO |
2:26 PM | Discussion | |
2:29 PM | Lightfield Medical | Chip Beresetka, MD, Co-founder |
2:34 PM | Rebion | Mark Maire, CEO |
2:39 PM | Discussion | |
2:42 PM | Conclusion | Rajesh Rajpal, MD |
2:43 PM | End of Session |
Anchor 1
bottom of page